You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

Article metrics

Article menu

Download PDFPDF

XML
Pharmacology and therapeutics
Original research
Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

 

Online download statistics by month:

Online download statistics by month: March 2020 to April 2024

AbstractFullPdf
Mar 202033432552
May 2020464515
Jun 2020434317
Jul 2020383812
Aug 2020433939
Sep 202036359
Oct 2020262314
Nov 2020302618
Dec 2020373127
Jan 2021191813
Feb 2021201917
Mar 2021363319
Apr 2021292918
May 2021292821
Jun 2021252413
Jul 2021171713
Aug 202118166
Sep 2021181911
Oct 2021242227
Nov 2021131227
Dec 2021414019
Jan 2022302617
Feb 202233349
Mar 2022312810
Apr 2022252410
May 2022433815
Jun 2022272417
Jul 202216169
Aug 2022212017
Sep 2022161517
Oct 2022241913
Nov 202219186
Dec 202222239
Jan 202319168
Feb 2023252312
Mar 202334335
Apr 202320198
May 2023302711
Jun 202319187
Jul 202317165
Aug 202322215
Sep 2023653
Oct 202321223
Nov 202327227
Dec 202345143610
Jan 202421219
Feb 202423219
Mar 2024141329
Apr 2024302629
Total20081906716